Sequana Medical NV (EBR:SEQUA)
Belgium · Delayed Price · Currency is EUR 0.6110
0.00 (0.00%)
Apr 28, 2026, 5:35 PM CET
Sequana Medical NV Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 7.31 | 3.81 | 2.58 | 18.87 | 9.6 | 11.02 |
Cash & Short-Term Investments | 7.31 | 3.81 | 2.58 | 18.87 | 9.6 | 11.02 |
Cash Growth | 92.11% | 47.34% | -86.31% | 96.61% | -12.85% | 97.19% |
Accounts Receivable | - | - | 0.04 | 0.11 | 0.08 | 0.02 |
Other Receivables | 1.13 | 0.86 | 1.69 | 1.77 | 1.37 | 1.24 |
Total Trade Receivables | 1.13 | 0.86 | 1.73 | 1.89 | 1.45 | 1.27 |
Inventory | 2.45 | 2.05 | 2.3 | 2.62 | 2.14 | 1.47 |
Other Current Assets | 0.51 | 0.26 | 1.06 | 1.19 | 0.77 | 0.62 |
Total Current Assets | 10.58 | 6.42 | 6.3 | 23.09 | 12.89 | 13.44 |
Net Property, Plant & Equipment | 1.87 | 1.77 | 2.32 | 2.07 | 1.27 | 0.7 |
Other Intangible Assets | 0.26 | - | - | - | - | - |
Other Long-Term Assets | 1.86 | 1.75 | 1.49 | 0.87 | 0.55 | 0.07 |
Total Assets | 14.57 | 9.94 | 10.1 | 26.03 | 14.71 | 14.21 |
Liabilities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Accounts Payable | 1.12 | 1.89 | 2.74 | 3.23 | 2.19 | 2.01 |
Accrued Expenses | 4.18 | 4.98 | 6.9 | 7.17 | 5.21 | 2.75 |
Short-Term Debt | 47.01 | 47.09 | 10.59 | 6.05 | - | - |
Current Portion of Leases | 0.25 | 0.06 | 0.27 | 0.31 | 0.28 | 0.26 |
Unearned Revenue | - | - | 0.17 | 0.16 | 0.17 | 0.79 |
Other Current Liabilities | 1.68 | 1.69 | 2.26 | 1.81 | 1.92 | 1.52 |
Total Current Liabilities | 52.16 | 53.21 | 19.47 | 15.15 | 7.18 | 5.97 |
Long-Term Debt | - | - | 8.97 | 12.19 | 7.32 | 7.47 |
Long-Term Leases | 0.73 | 0.36 | 0.46 | 0.61 | 0.48 | 0.12 |
Other Long-Term Liabilities | 0.86 | 0.75 | 0.67 | 0.23 | 0.51 | 0.54 |
Total Long-Term Liabilities | 1.59 | 1.11 | 10.1 | 13.03 | 8.31 | 8.13 |
Total Liabilities | 53.75 | 54.32 | 29.57 | 28.18 | 15.49 | 14.1 |
Shareholders' Equity
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Common Stock | 5.93 | 4.6 | 2.93 | 2.46 | 1.92 | 1.64 |
Additional Paid-in Capital | 208.98 | 201.56 | 185.64 | 170.32 | 142.43 | 119.33 |
Accumulated Other Comprehensive Income | 0.91 | 0.85 | 0.88 | 0.95 | 0.22 | 0.48 |
Retained Earnings | -254.99 | -251.4 | -208.92 | -175.88 | -145.36 | -121.33 |
Shareholders' Equity | -39.17 | -44.38 | -19.47 | -2.15 | -0.79 | 0.11 |
Total Liabilities & Equity | 14.57 | 9.94 | 10.1 | 26.03 | 14.71 | 14.21 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Total Debt | 47.99 | 47.5 | 20.29 | 19.16 | 8.09 | 7.86 |
Net Cash (Debt) | -40.67 | -43.69 | -17.7 | -0.29 | 1.52 | 3.16 |
Net Cash Growth | - | - | - | - | -52.00% | 33.66% |
Net Cash Per Share | -0.87 | -1.19 | -0.66 | -0.01 | 0.08 | 0.21 |
Book Value | -39.17 | -44.38 | -19.47 | -2.15 | -0.79 | 0.11 |
Book Value Per Share | -0.84 | -1.21 | -0.73 | -0.09 | -0.04 | 0.01 |
Tangible Book Value | -39.44 | -44.38 | -19.47 | -2.15 | -0.79 | 0.11 |
Tangible Book Value Per Share | -0.84 | -1.21 | -0.73 | -0.09 | -0.04 | 0.01 |